This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Present Status of Testosterone Therapy

WALTER G. KING, M.D.

AMA Arch Surg. 1950;61(4):630-653.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THIS report is concerned with the experiences of my colleagues and me during the past three years in the use of testosterone in the treatment of 18 patients with far advanced carcinoma of the breast. From these experiences we have drawn certain conclusions as to its place in the treatment of this type of malignant growth.

Although carcinoma of the breast averages about 20 to 25 per cent of all cancer in women and in them is the commonest form of the disease,¹ it is less rapidly fatal than most neoplasms of this histologic type.

The life expectancy of untreated patients has been repeatedly computed and averages about three and a third years. For this reason the custom of speaking of two, three or five year survivals in measuring the efficacy of any given form of treatment for cancer of the breast is of doubtful value. Cade^la has . . . [Full Text PDF of this Article]

Author Affiliations
ANN ARBOR, MICH.

From the Department of Surgery, University of Michigan Medical School.

Footnotes
Read at the Seventh Annual Meeting of the Central Surgical Association, Chicago, Feb. 17, 1950.

Dr. Isadore Lampe, Professor of Roentgenology, University of Michigan, assisted in the roentgenologic aspects of this work.

The testosterone used in this study was supplied through the courtesy of the Schering Corporation and of Dr. Edward Henderson, Bloomfield, N. J.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?